应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BIB Ultra纳斯达克生物科
交易中 09-10 11:37:07 EDT
111.15
-1.66
-1.47%
最高
111.72
最低
109.30
成交量
6,806
今开
111.67
昨收
112.81
日振幅
2.15%
总市值
9,670万
流通市值
9,670万
总股本
87.00万
成交额
75.33万
换手率
0.78%
流通股本
87.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
安进（AMGN）联合疗法III期临床达主要终点
金吾财讯 · 09-09 16:59
安进（AMGN）联合疗法III期临床达主要终点
安进-阿斯利康肺癌联合用药在后期临床试验中显著提升生存率
格隆汇 · 09-09 10:39
安进-阿斯利康肺癌联合用药在后期临床试验中显著提升生存率
市场风向标：安进股价遭受重创
投资观察 · 09-09 05:35
市场风向标：安进股价遭受重创
Assembly Biosciences有望获得高达2.8亿美元里程碑付款及美国境外特许权使用费
美股速递 · 09-09 04:02
Assembly Biosciences有望获得高达2.8亿美元里程碑付款及美国境外特许权使用费
Assembly Biosciences旗下Gs-1179预计2026年底前将推进至生殖器疱疹二期临床试验阶段
美股速递 · 09-09 04:02
Assembly Biosciences旗下Gs-1179预计2026年底前将推进至生殖器疱疹二期临床试验阶段
Assembly Biosciences：吉利德独享HSV HPI项目临床开发与商业化权利
美股速递 · 09-09 04:01
Assembly Biosciences：吉利德独享HSV HPI项目临床开发与商业化权利
Assembly Biosciences行使与吉利德关于HSV解旋酶-引物酶抑制剂项目的美国利润分成选择权
美股速递 · 09-09 04:01
Assembly Biosciences行使与吉利德关于HSV解旋酶-引物酶抑制剂项目的美国利润分成选择权
安进股价或创二十余年来最大单日跌幅
投资观察 · 09-09 02:23
安进股价或创二十余年来最大单日跌幅
安进股价下跌7%，创下自2025年6月以来最大单日跌幅。
智通财经 · 09-08 21:30
安进股价下跌7%，创下自2025年6月以来最大单日跌幅。
安进Phase 3 Dellphi-305研究重大突破：总生存期获益显著优于度伐利尤单抗单药治疗
美股速递 · 09-08 21:07
安进Phase 3 Dellphi-305研究重大突破：总生存期获益显著优于度伐利尤单抗单药治疗
Imdelltra®联合Imfinzi®在一线广泛期小细胞肺癌中展现里程碑式总生存期改善
美股速递 · 09-08 21:04
Imdelltra®联合Imfinzi®在一线广泛期小细胞肺癌中展现里程碑式总生存期改善
BMO下调安进及BioNTech评级至“与大市同步”
格隆汇 · 09-08 20:59
BMO下调安进及BioNTech评级至“与大市同步”
美股盘前｜英特尔、甲骨文涨超4%；诺华重挫12%，IONIS下跌10%；阿斯麦新一代EUV光刻机获台积电和三星使用承诺
老虎资讯综合 · 09-08 20:01
美股盘前｜英特尔、甲骨文涨超4%；诺华重挫12%，IONIS下跌10%；阿斯麦新一代EUV光刻机获台积电和三星使用承诺
美股异动｜安进盘前跌5.4%，诺华同靶点药物III期临床失败，Lp(a)赛道遭重创
中金财经 · 09-08 17:07
美股异动｜安进盘前跌5.4%，诺华同靶点药物III期临床失败，Lp(a)赛道遭重创
安进股价盘前下跌5.4%；竞争对手诺华的胆固醇药物后期临床试验失败。
智通财经 · 09-08 16:28
安进股价盘前下跌5.4%；竞争对手诺华的胆固醇药物后期临床试验失败。
富国银行上调安进目标价至435美元
格隆汇 · 09-08 11:12
富国银行上调安进目标价至435美元
一周两度受挫！诺华(NVS.US)心脏病重磅药III期折戟，股价大跌安进(AMGN.US)“躺枪”
智通财经 · 09-07
一周两度受挫！诺华(NVS.US)心脏病重磅药III期折戟，股价大跌安进(AMGN.US)“躺枪”
安进（AMGN）罕见病药物Tavneos将于27年3月1日被彻底撤销英国上市许可
金吾财讯 · 09-02
安进（AMGN）罕见病药物Tavneos将于27年3月1日被彻底撤销英国上市许可
高盛9月“确信名单”更新：美股纳入福泰制药(VRTX.US) 欧股力推莱茵、Adyen和塔兰克斯
智通财经 · 09-02
高盛9月“确信名单”更新：美股纳入福泰制药(VRTX.US) 欧股力推莱茵、Adyen和塔兰克斯
高盛9月“确信名单”更新：美股纳入福泰制药 欧股力推莱茵、Adyen和塔兰克斯
智通财经 · 09-02
高盛9月“确信名单”更新：美股纳入福泰制药 欧股力推莱茵、Adyen和塔兰克斯
加载更多
公司概况
公司名称：
Ultra纳斯达克生物科
所属市场：
NASDAQ
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra纳斯达克生物科","latestPrice":111.15,"timestamp":1789054316958,"preClose":112.8071,"halted":0,"volume":6806,"delay":0,"changeRate":-0.014689678220608453,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"交易中","change":-1.6571,"latestTime":"09-10 11:37:07 EDT","open":111.6712,"high":111.72,"low":109.3,"amount":753275.4889,"amplitude":0.021453,"askPrice":110.11,"askSize":190,"bidPrice":109.85,"bidSize":20,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":112.8071,"sharesOutstanding":1040000,"nav":114.8214,"aum":99894618,"dividendRate":0.002943,"bidAskSpread":0.003038,"preHourTrading":{"tag":"盘前","latestPrice":111.98,"preClose":112.8071,"latestTime":"09:29 EDT","volume":20,"amount":2222.49008,"timestamp":1789046999012,"change":-0.8271,"changeRate":-0.007332,"amplitude":0.021453},"postHourTrading":{"tag":"盘后","latestPrice":109.888,"preClose":112.8071,"latestTime":"19:30 EDT","volume":550,"amount":60459.6351,"timestamp":1788996609226,"change":-2.9191,"changeRate":-0.025877,"amplitude":0.027746},"volumeRatio":1.732128,"impliedVol":0.4548,"impliedVolPercentile":0.5458},"requestUrl":"/m/hq/s/BIB","defaultTab":"news","newsList":[{"id":"2666712586","title":"安进（AMGN）联合疗法III期临床达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2666712586","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666712586?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:59","pubTimestamp":1788944360,"startTime":"0","endTime":"0","summary":"金吾财经 | 安进公布，双特异性T细胞衔接器Imdelltra联合阿斯利康PD-L1抑制剂英飞凡，在广泛期小细胞肺癌的后期临床试验中实现总生存期延长。这家加州生物制药企业披露III期DeLLphi-305研究中期数据，该试验达成广泛期小细胞肺癌患者总生存期主要终点。该项全球试验评估该组合作为一线维持治疗，受试者既往接受过包含英飞凡的治疗且病情未发生进展。研究同时达成无进展生存期、客观缓解率两项次要终点。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2456880835.USD","LU2236285917.USD","BK4585","LU1267930573.SGD","AZN","SG9999001440.SGD","LU1571399168.USD","PJP","BBH","TBXU","AMGN","LU2112291526.USD","BIB","LU2237443895.HKD","BK4534","LU2237443978.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","AZNH","LU0109394709.USD","LU0029864427.USD","LU0432979614.USD","PBE","IBBQ","BK4599","LU1023059063.AUD","LU2468319806.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0128525929.USD","LU0122379950.USD","BK4139","LU2237443622.USD","IBB","LU2462157665.USD","BK4568","LU2242646821.SGD","LU0708994859.HKD","LU0289739699.SGD","LU1829250122.USD","LU2237443382.USD","LU2242652126.USD","LU0868494617.USD","BK4566","BK4533","LU2089984988.USD","BK4581","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309213","title":"安进-阿斯利康肺癌联合用药在后期临床试验中显著提升生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309213","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666309213?lang=zh_cn&edition=full","pubTime":"2026-09-09 10:39","pubTimestamp":1788921579,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["PBE","LU0058720904.USD","LU1571399168.USD","BK4139","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU0109394709.USD","MDTX","IBBQ","BK4533","LU0122379950.USD","LU2468319806.SGD","LU2112291526.USD","BK4588","LU0320765992.SGD","LU1057294990.SGD","IE0009355771.USD","BMED","BK4566","IE00B4R5TH58.HKD","PSYK","AMGN","TBXU","IBBJ","BK4599","PJP","SG9999001440.SGD","BIB","LU0889565916.HKD","LU2089984988.USD","LU1061106388.HKD","LU2242652126.USD","IBB","BK4581","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","LU1983299246.USD","LU0289739699.SGD","LU0868494617.USD","LU1023059063.AUD","BBH","BK4534","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112638879","title":"市场风向标：安进股价遭受重创","url":"https://stock-news.laohu8.com/highlight/detail?id=1112638879","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112638879?lang=zh_cn&edition=full","pubTime":"2026-09-09 05:35","pubTimestamp":1788903338,"startTime":"0","endTime":"0","summary":"“这对安进而言，堪称最糟糕的结局。”——巴克莱分析师艾米丽·菲尔德如此评价。此前，诺华制药公布了其心脏病药物令人失望的试验结果，这一披露不仅让诺华自身承压，更给安进旗下一款重磅药物蒙上了厚厚的阴影。","market":"us","thumbnail":"https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","IBBQ","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4139","BK4581","LU1057294990.SGD","PJP","LU2112291526.USD","BK4533","LU0109394709.USD","IE0002141913.USD","SG9999001440.SGD","IE0009355771.USD","LU1983299246.USD","IBB","BK4588","BIB","LU1023059063.AUD","LU0889565916.HKD","LU2242646821.SGD","TBXU","AMGN","LU0289739699.SGD","LU1061106388.HKD","LU0868494617.USD","LU2242652126.USD","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0122379950.USD","LU2089984988.USD","BK4534","PBE","BBH","BK4566","LU0320765992.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136308873","title":"Assembly Biosciences有望获得高达2.8亿美元里程碑付款及美国境外特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136308873?lang=zh_cn&edition=full","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露，其在海外市场具备资格获取最高达2.8亿美元的里程碑款项，外加相应特许权使用费收入。据悉，这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言，这笔潜在收入不仅反映其管线资产的外部合作价值，也可能为其后续研发投入提供坚实支撑。市场人士认为，此类非美国市场的收益结构有助于分散地域风险，增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","IE00B19Z3581.USD","SG9999015986.USD","LU1066053197.SGD","BMED","BK4585","LU1934455863.HKD","BK4588","LU1037948541.HKD","IE0002270589.USD","LU0109394709.USD","LU0289739699.SGD","LU0882574055.USD","LU1057294990.SGD","BK4568","LU1430594728.SGD","LU2089984988.USD","LU2324357040.USD","ASMB","SG9999015978.USD","LU0861579265.USD","LU0114720955.EUR","LU2357627491.SGD","LU0965509010.AUD","LU1066051498.USD","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","BBH","LU1934455194.USD","BK4532","IBB","LU0234570918.USD","BK4139","IE00B19Z3B42.SGD","BK4578","IE00BSNM7G36.USD","LU0859254822.USD","LU0320765992.SGD","LU0889565916.HKD","LU1839511570.USD","TBXU","SG9999015952.SGD","LU1674673691.USD","BK4550","BK4583","BK4566","IE00BZ1G4Q59.USD","LU0823416689.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU1674673428.USD","SG9999015945.SGD","IBBQ","LU1061106388.HKD","LU0965508806.USD","MEDI","IE00B3T34201.USD","GILD","LU0965509283.SGD","LU0122379950.USD","LU1585245621.USD","LU1934455277.USD","LU1037948897.HKD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0058720904.USD","BIB","TMED","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179预计2026年底前将推进至生殖器疱疹二期临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154623157?lang=zh_cn&edition=full","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布，其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病，全球患者群体庞大，对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程，以期尽早为患者带来新的治疗选择。业内分析人士指出，若Gs-1179能够顺利通过后续试验的严格考验，将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B19Z3B42.SGD","LU0823416689.USD","IE0002270589.USD","IE00BKVL7J92.USD","BK4139","LU1674673691.USD","IE00B19Z3581.USD","SG9999015952.SGD","BK4568","LU1037948897.HKD","LU1778281490.HKD","BMED","TBXU","LU1430594728.SGD","TMED","MEDI","BK4585","LU1839511570.USD","IBBQ","BK4588","LU1061106388.HKD","BBH","LU1934455863.HKD","LU0289739699.SGD","BK4583","LU0965509010.AUD","LU0882574055.USD","LU1571399168.USD","BK4550","LU1066053197.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU0889565916.HKD","LU2089984988.USD","IE00B3T34201.USD","LU2087621335.USD","LU1934455194.USD","IE00B7SZLL34.SGD","BK4578","LU0965509101.SGD","LU0122379950.USD","LU2112291526.USD","BIB","LU0965509283.SGD","LU2468319806.SGD","LU2357627491.SGD","SG9999015945.SGD","LU0058720904.USD","LU1057294990.SGD","LU0320765992.SGD","GILD","LU1037948541.HKD","LU0859254822.USD","ASMB","LU0114720955.EUR","LU1023059063.AUD","SG9999015978.USD","BK4532","LU1066051498.USD","SG9999015986.USD","LU0965508806.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0861579265.USD","LU1674673428.USD","LU0109394709.USD","IBB","LU0234570918.USD","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences：吉利德独享HSV HPI项目临床开发与商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115029168?lang=zh_cn&edition=full","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化，吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言，此举不仅明确了合作伙伴的战略优先级，也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出，HSV HPI项目的独家授权，反映了吉利德在抗病毒治疗领域持续加码的雄心，同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1934455277.USD","BMED","LU0859254822.USD","LU2468319806.SGD","BBH","LU2112291526.USD","LU1037948541.HKD","IE00B19Z3B42.SGD","BK4532","TBXU","LU1430594728.SGD","BK4583","GILD","LU2087621335.USD","LU1023059063.AUD","BK4578","IE00BKVL7J92.USD","LU0823416689.USD","LU0882574055.USD","LU1066053197.SGD","BK4568","BK4588","LU0289739699.SGD","LU1571399168.USD","LU1585245621.USD","LU1778281490.HKD","LU2089984988.USD","LU0109394709.USD","LU2357627491.SGD","SG9999015952.SGD","MEDI","LU0965508806.USD","LU1934455194.USD","IE00BSNM7G36.USD","TMED","IE00B19Z3581.USD","LU1061106388.HKD","LU0965509101.SGD","LU0122379950.USD","LU1057294990.SGD","BK4550","IE00B7SZLL34.SGD","LU1674673428.USD","BK4566","LU2324357040.USD","LU0889565916.HKD","LU1066051498.USD","SG9999015978.USD","IE0002270589.USD","LU0320765992.SGD","SG9999015945.SGD","LU0861579265.USD","LU1674673691.USD","ASMB","BK4139","LU1037948897.HKD","IBB","BIB","IBBQ","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU0965509283.SGD","LU0965509010.AUD","LU0234570918.USD","IE00B3T34201.USD","BK4585","LU0058720904.USD","SG9999015986.USD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使与吉利德关于HSV解旋酶-引物酶抑制剂项目的美国利润分成选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179230759?lang=zh_cn&edition=full","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段，有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权，Assembly Biosciences将能够分享该药物在美国市场的未来收益，同时借助吉利德在抗病毒领域的深厚积累与市场渠道，共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0823416689.USD","LU1061106388.HKD","SG9999015986.USD","LU1430594728.SGD","LU0289739699.SGD","LU0882574055.USD","TMED","SG9999015945.SGD","BK4583","LU0965509283.SGD","LU1057294990.SGD","LU1037948897.HKD","LU1037948541.HKD","LU0889565916.HKD","LU1585245621.USD","BK4566","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU0109394709.USD","LU2357627491.SGD","BK4568","BIB","BBH","LU1934455863.HKD","IE00B19Z3581.USD","LU0122379950.USD","BK4588","BMED","GILD","IE00BSNM7G36.USD","LU0859254822.USD","BK4578","IE0002270589.USD","LU2087621335.USD","BK4532","ASMB","LU0058720904.USD","LU1066053197.SGD","LU0861579265.USD","LU1023059063.AUD","LU1778281490.HKD","LU1934455194.USD","LU2324357040.USD","LU2468319806.SGD","IBB","LU1839511570.USD","MEDI","BK4585","LU0320765992.SGD","TBXU","BK4139","LU2112291526.USD","LU1066051498.USD","LU0965509101.SGD","SG9999015952.SGD","LU0965508806.USD","IBBQ","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1571399168.USD","LU1674673428.USD","LU1674673691.USD","SG9999015978.USD","LU2089984988.USD","LU1934455277.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU0965509010.AUD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安进股价或创二十余年来最大单日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111756325?lang=zh_cn&edition=full","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%，这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索，源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂，试验宣告失败。周二，礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧，使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"hk","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","04332","LU2468319806.SGD","PJP","TBXU","LU1983299246.USD","BK4588","IE00BJT1NW94.SGD","PBE","BK4533","LU1061106388.HKD","LU2242652126.USD","AMGN","BK4599","SG9999001440.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0889565916.HKD","BIB","BK4566","IE00B2B36J28.USD","LU0868494617.USD","LU2242646821.SGD","IE0009355771.USD","IBB","IE0002141913.USD","LU1571399168.USD","IBBQ","BBH","LU0122379950.USD","BK4581","LU1057294990.SGD","BK4139","LU0058720904.USD","LU1023059063.AUD","LU2089984988.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安进股价下跌7%，创下自2025年6月以来最大单日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665375527?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PBE","LU0058720904.USD","LU1571399168.USD","BK4139","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU0109394709.USD","IBBQ","BK4533","LU0122379950.USD","LU2468319806.SGD","LU2112291526.USD","BK4588","LU0320765992.SGD","LU1057294990.SGD","IE0009355771.USD","BK4566","IE00B4R5TH58.HKD","AMGN","TBXU","BK4599","PJP","SG9999001440.SGD","BIB","LU0889565916.HKD","LU2089984988.USD","LU1061106388.HKD","LU2242652126.USD","IBB","BK4581","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585","LU1983299246.USD","LU0289739699.SGD","LU0868494617.USD","LU1023059063.AUD","BBH","BK4534","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安进Phase 3 Dellphi-305研究重大突破：总生存期获益显著优于度伐利尤单抗单药治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115495471?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布，其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比，该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现，无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露，但安进方面表示，其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进，安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4585","BK4599","LU1057294990.SGD","IBBQ","LU1571399168.USD","AMGN","IE00B2B36J28.USD","PJP","BK4534","IE00BJJMRZ35.SGD","PBE","LU2112291526.USD","BK4581","LU0289739699.SGD","TBXU","LU2089984988.USD","LU2468319806.SGD","BK4139","LU2242652126.USD","IBB","LU0122379950.USD","IE0009355771.USD","LU0868494617.USD","LU1061106388.HKD","SG9999001440.SGD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD","BK4588","LU0058720904.USD","LU1983299246.USD","BK4533","LU1023059063.AUD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®联合Imfinzi®在一线广泛期小细胞肺癌中展现里程碑式总生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109517247?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法，于一线广泛期小细胞肺癌治疗领域，取得了具有划时代意义的总生存期提升。这一突破性进展，不仅为患者带来了新的曙光，也重塑了该领域的治疗格局。从数据层面观察，联合治疗方案的生存获益尤为显著，堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2112291526.USD","LU0122379950.USD","BIB","BK4599","PBE","IBBQ","IE00BJT1NW94.SGD","IBB","IE00B4R5TH58.HKD","LU2089984988.USD","LU0058720904.USD","LU1057294990.SGD","BK4566","LU1023059063.AUD","LU1571399168.USD","SG9999001440.SGD","LU2242652126.USD","BK4588","IE00BJJMRZ35.SGD","PJP","LU2242646821.SGD","AMGN","LU0889565916.HKD","IE00B2B36J28.USD","LU0109394709.USD","LU1061106388.HKD","BK4581","BK4534","BBH","BK4585","LU0868494617.USD","BK4139","TBXU","LU1983299246.USD","IE00BFTCPJ56.SGD","BK4533","LU0320765992.SGD","LU2468319806.SGD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下调安进及BioNTech评级至“与大市同步”","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665387373?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0289739699.SGD","PJP","BBH","LU0868494617.USD","BK4139","LU1983299246.USD","LU2112291526.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4533","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IBB","LU1571399168.USD","LU2242646821.SGD","LU0058720904.USD","SG9999001440.SGD","PBE","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","IBBQ","TBXU","LU0122379950.USD","IE00BJT1NW94.SGD","BIB","IE0002141913.USD","BK4585","AMGN","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4566","LU2468319806.SGD","LU1057294990.SGD","LU0109394709.USD","BK4599","BK4581","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盘前｜英特尔、甲骨文涨超4%；诺华重挫12%，IONIS下跌10%；阿斯麦新一代EUV光刻机获台积电和三星使用承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103332998?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"sg","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061474960.USD","LU0823417737.USD","LU2129689514.USD","CHAT","IE00B7SZL793.SGD","LU2663582299.SGD","BK4139","LU0210528500.USD","LU1267930813.SGD","LU0316494557.USD","LU0823414478.USD","LU1868838027.USD","GXPE","LU2471134952.CNY","LU0795875169.SGD","CGNG","OZEM","LU0859254822.USD","LU1064131342.USD","ASIA","BK4213","LU1935042991.SGD","LU1720051017.SGD","IE00B1BXHZ80.USD","LU0985489474.SGD","LU2272731600.USD","LU0889565916.HKD","LU0077335932.USD","LU0321505439.SGD","BK7104","LU0234570918.USD","LU0417517546.SGD","LU1489326972.SGD","IE00BYQQ9H92.USD","LU1868837565.USD","BK4608","LU0124676726.USD","FDTX","CWI","DRIV","LU0965509283.SGD","TBXU","IE00BWXC8680.SGD","LU2108987350.USD","LU2211815571.USD","LU1935042488.USD","SPRX","LU1894683264.USD","LU0122376428.USD","SG9999003800.SGD","LU2054465674.USD","IBB","LU1046421795.USD","CGDG","LU0661504455.SGD","QTUP","BK4157","LU0949170772.SGD","LU1267930490.SGD","LU0432979614.USD","LU2750360997.AUD","IE000F7OJYX1.SGD","LU2271345857.HKD","LU0094547139.USD","LU0310799852.SGD","LU0154245756.USD","IFLR","LU0868486357.SGD","TDIV","LU0882574055.USD","CNEQ","LU1791710400.SGD","ORCX","LU1934455277.USD","SOXX","LU0572940350.SGD","LU0203347892.USD","HK0000304805.HKD","GNOM","LU0072461881.USD","LU1674673691.USD","TEK","EMC","IE00BKPKM429.USD","IE000SO60NU8.SGD","AVEM","LU0541501648.USD","LU1430597077.USD","LU2498475776.HKD","LU0345780950.USD","BK4529","LU2506951792.HKD","BK4147","LU0029874061.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","LU0211326755.USD","LU1734074674.USD","IE0009355771.USD","SGXZ81514606.USD","LU0368265418.SGD","LINT","LU0211331839.USD","LU2360108059.USD","LU2458330169.SGD","LU0878005551.USD","LU0130103400.USD","SPY","DIA","LU2357125470.USD","BK4023","LU0353189763.USD","LU1282649810.SGD","IE00BMPRXQ63.HKD","LU0823414551.USD","LU0823038988.USD","LU2087621335.USD","INTW","LU2360032135.SGD","IE00BD6J9T35.USD","BK4526","BK4566","LU0323591593.USD","PQNT","LU1057294990.SGD","LU0792757196.USD","PJP","BGIA","CORO","LU2087625088.SGD","LU2129689431.USD","BK4578","CNAV","LU1366333091.USD","LU0211327993.USD","LU1291159041.SGD","LU0648000940.SGD","LU2468319806.SGD","IE00BQXX3F31.USD","BK4599","LU0310800965.SGD","LU0912757837.SGD","WEEI","LU2430703178.SGD","TRUN","LU1929549753.HKD","LU1839511570.USD","LU1093756325.SGD","LEGR","IE00BMPRXN33.USD","OGIG","IE00B3CCJ963.GBP","03145","LU2491050154.USD","BK4538","LU2860962120.EUR","LU0787776722.HKD","THNR","GNMX","IE0002141913.USD","LU1803068979.SGD","SG9999001424.SGD","LU2505996681.GBP","IE00BFXG1179.USD","WUGI","XLE","IE00BJT1NW94.SGD","LU0477156953.USD","LU1162221912.USD","BK5113","LU0444973449.USD","LU2764263039.SGD","IEFA","LU2430703095.HKD","UDOW","IE0000B7K699.USD","IE00B1XK9C88.USD","BK4504","BK4585","LU1366192091.USD","LU2931357623.SGD","LU2750360641.GBP","LU1712237335.SGD","LU0256331488.USD","LU2430703251.USD","LU2324357040.USD","LU1582987324.SGD","TTEQ","LU2362541273.HKD","LU0225283273.USD","IE00BQXX3D17.EUR","LU2347655156.SGD","IE000WAW04H5.SGD","LU2063271972.USD","LU1323610961.USD","LU0175139822.USD","LU0689626769.HKD","LU1720051108.HKD","LU1150488218.USD","FTXL","LU1883866441.USD","LU2041044095.USD","IE00B19Z3581.USD","LU0011850046.USD","LU1989764664.SGD","LU2237443382.USD","FTXN","LU1992135472.HKD","IE00BLSP4239.USD","IE00BGHQF524.EUR","PXE","IGE","LU2112291526.USD","LU1282649067.USD","LU2471134523.USD","LU1718418525.SGD","LU1023057109.AUD","LU1150488135.SGD","LU0130517989.USD","FCG","IE00B4R5TH58.HKD","DDM","LU0345770993.USD","LU1935042215.USD","LU2298321311.HKD","LU0203345920.USD","LU1823568750.SGD","LU1582987597.SGD","DOG","BK4532","LU2506951958.HKD","LU2746668461.USD","SG9999015341.SGD","CRAK","IE00BHPRN162.USD","IBBQ","LU2272731865.HKD","LU0496365809.HKD","IYE","BK4534","LU1934455863.HKD","LU0274383776.USD","LU1974910355.USD","LU0823421333.USD","LU0823421416.USD","IE00BBT3K403.USD","LU2242646821.SGD","LU0208291251.USD","LU0320765646.SGD","FOTO","IE0004086264.USD","BK4543","IE00BFXG0V08.USD","OILT","LU0976567544.SGD","CHPS","LU2326559502.SGD","BK4591","LU2089284900.SGD","LU2592432038.USD","BK4548","LU0251132253.USD","LU2487616109.SGD","LU0058720904.USD","LU0170899867.USD","LU0889566641.SGD","LU0320765992.SGD","LU0957808578.USD","LU1988902786.USD","EFA","LU0082616367.USD","LU1732800096.USD","BK4575","LU2357305700.SGD","LU0882747503.HKD","AIS","LU0109392836.USD","LU0823039010.USD","LU0081259029.USD","LU2237443549.SGD","ORCS","LU2290526834.HKD","LU0384037296.USD","LU0345781412.USD","LU2720916845.USD","IE0009356076.USD","LU1989764748.USD","LU2294711713.HKD","LU0056508442.USD","LU0788109394.HKD","LU1992135399.USD","BK4602","LU0353189680.USD","LU0612318971.USD","LU1989771016.USD","LU1989772840.SGD","IE000MB6IJN5.SGD","IE00BKVL7J92.USD","LU1623119135.USD","VDE","AVXC","LU0476273544.USD","IE00BZ199S13.USD","LU1548497426.USD","LU0488056044.USD","LU0823416689.USD","IE00BLSP4452.SGD","LU1153585028.USD","LU1815333072.USD","LU2092937221.SGD","EGGY","CHPX","LU2471134879.HKD","LU0444971666.USD","BK4559","LU0868494708.USD","MEDX","LU0541502299.USD","LU0823417653.USD","LU2602419157.SGD","LU0359201885.HKD","LU2896262040.SGD","LU0210536198.USD","LU1069347547.HKD","LU0345774391.USD","ORCU","IE00BKDWB100.SGD","BK4527","LU1804176565.USD","LU1935043023.USD","LU2247934214.USD","LU2148611432.USD","LU0278409577.USD","LU0264606111.USD","ORAC","HYDR","IEO","ASMH","LU0154236417.USD","LU0234572021.USD","CQTM","LU1003077747.HKD","LU0098860793.USD","LU0572939691.SGD","LU0162691827.USD","IE00B19Z4B17.USD","LU2491050071.SGD","IGV","LU0053666078.USD","BK4121","BK4581","LU0823434583.USD","SDOW","ESIM","IE00B3M56506.USD","SG9999014575.USD","LU0683600562.USD","MEMX","SG9999002224.SGD","LU1852331112.SGD","LU0154245673.USD","EPAI","LU0466842654.USD","LU1037948541.HKD","IE0031619046.USD","LU0359202008.SGD","LU2272731782.SGD","LU0823434740.USD","BK4592","LU0052756011.USD","LU0084288322.USD","DBEF","IE00B775SV38.USD","LU1066053197.SGD","LU1093756168.USD","LU0431992006.USD","SG9999011175.SGD","LU2764263203.CNY","LU1435385759.SGD","LU1429558221.USD","LU1585245621.USD","LU0070217475.USD","LU1989772923.USD","TNGY","LU0157215616.USD","LU0138981039.USD","LU1023059063.AUD","LU2746668974.SGD","FFGX","LU2111349929.HKD","SG9999015358.SGD","LU0642271901.SGD","NVS","CGIC","SPWO","GSID","LU2471134796.USD","LU0158827948.USD","LU0149725797.USD","BK4515","SG9999001176.USD","INTC","FENI","LU2322448957.HKD","SG9999000418.SGD","SG9999004220.SGD","BAI","LU2264538146.SGD","LU0742534661.SGD","LU2242649171.HKD","LU0612318385.USD","LU1732799900.SGD","LU0868494617.USD","IE00B3S45H60.SGD","LU2125154935.USD","ORCL","XNTK","LU0965508806.USD","WQTM","BK4007","BK4097","IE00B2B36J28.USD","HBMX","SGXZ51526630.SGD","LU1917777945.USD","LU0289960550.SGD","LU1571399168.USD","LU0528227936.USD","BK4535","LU2125154778.USD","LU0130102774.USD","LU0433182093.SGD","LU0158827781.USD","EMM","LU1582986433.USD","LU0238689110.USD","LU1642822529.SGD","LU2462611646.USD","IXC","ORCZ","LU0143551892.USD","IE00B5TLWC47.USD","SGXZ57979304.SGD","LU0068578508.USD","RSPG","IE0004445239.USD","BK4505","LU1211504680.USD","IE00B19Z3B42.SGD","LU0266512127.USD","TEXU","LU1037948897.HKD","TINS","BK4605","ERX","SG9999002232.USD","LU0345769128.USD","LU0878866978.SGD","BK7095","LU2023251221.USD","LU2360107168.USD","SG9999001440.SGD","BK4148","LU0345774631.USD","LU0122379950.USD","LU0654597011.USD","LU2491049909.HKD","BK4533","LU1506573853.SGD","LU1861220033.SGD","LU0950375773.USD","SGXZ99366536.SGD","CGGO",".DJI","SG9999014542.SGD","LU0211328371.USD","DRLL","LU0320765489.SGD","LU2764262908.HKD","LU0109394709.USD","IE00B7SZLL34.SGD","LU0630314457.HKD","LU1815336760.USD","LU2462591277.SGD","LU0965509101.SGD","LU2089283258.USD","IE00B2Q91V27.USD","LU0738911758.USD","LU2133065610.SGD","ADVE","QQQA","LU1582986359.USD","LU2506952170.USD","IE0004091025.USD","LU1430594728.SGD","LU2089984988.USD","LU0048584097.USD","BK4512","LU1201861249.SGD","LU1235294995.USD","LU0321505868.SGD","LU0545039389.USD","LU0289739699.SGD","LU0345769631.USD","LU0942090050.USD","LU1048588211.SGD","IE000BZT7R73.USD","BK4138","LU2265009873.SGD","LU2543165471.USD","LU1861215975.USD","DXD","BIB","IE0002270589.USD","LU2102340556.USD","LU0719512351.SGD","BK4588","FENY","BK4170","LU0097036916.USD","IE00B66KJ199.SGD","LU2362540622.SGD","03165","PBE","SG9999013999.USD","PPH","IE00BN8TJ469.HKD","LU2237957811.SGD","LU0251131958.USD","IE000M9KFDE8.USD","LU2360106780.USD","LU0211326839.USD","LU0048573561.USD","LU0300736492.USD","AIQ","LU1691799644.USD","LU0128525689.USD","LU2999663052.SGD","LU0266013472.USD","LU2129689605.HKD","BK4612","IE00BZ1G4Q59.USD","BK4503","LU0128526141.USD","LU0553294199.USD","LU0143863784.USD","IE00BQXX3C00.GBP","LU1316542783.SGD","LU0965509010.AUD","LU2250418816.HKD","IE00BSNM7G36.USD","LU2236285917.USD","LU0114720955.EUR","LU0957791311.USD","LU0795875086.SGD","LU1035773651.USD","LU0300736062.USD","LUMA","INYY","LU0266512473.USD","LU2322448791.USD","BK4082","CTEX","IE00B5949003.HKD","LU2237443622.USD","LU0980610538.SGD","KNOW","ILOW","LU2249611893.SGD","SG9999014559.SGD","PXI","LU0861579265.USD","LU1778281490.HKD","BK4570","LU2505996509.AUD","LU2237957902.USD","LU1674673428.USD","UMMA","LU1074936037.SGD","LU1894683348.USD","BK4516","LU2506951875.HKD","LU2473716301.USD","SPTE","SMH","LU0256863811.USD","BK4201","LU1983299246.USD","LU2106854487.HKD","LU2362541513.USD","LU0187121727.USD","LU0359201612.USD","IE00BMPRXR70.SGD","IE00BJJMRZ35.SGD","LU0889565833.HKD","LU1935043536.SGD","LU1066051498.USD","SG9999001176.SGD","BK4579","LU0314106906.USD","IE0034235303.USD","LU1267930227.SGD","LU0251142724.SGD","LU0878004406.USD","LU1508157978.USD","LU2458330243.SGD","LU2242652126.USD","DIG","LU0348723411.USD","BK4554","BK4550","LU0198837287.USD","SG9999002521.SGD","LU2237443978.SGD","BBH","INT","LU0143863198.USD","LU2211814178.USD","LU1791710582.SGD","LU2357627491.SGD","LU2954938101.SGD","LU0070302665.USD","LU2089985449.USD","BLOX","LU0267386448.USD","LU1201861165.SGD","LU0648001328.SGD","BK4141","LU1934455194.USD","HK0000304797.USD","BK4528","LU2028103732.USD","LU2506952097.USD","LU0072462343.USD","DBEU","LU1061106388.HKD","AVSE","LU1868837722.USD","LU2244417387.USD","LU2023250504.SGD","SG9999014567.USD","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股异动｜安进盘前跌5.4%，诺华同靶点药物III期临床失败，Lp(a)赛道遭重创","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665326953?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2112291526.USD","IE00BJT1NW94.SGD","PJP","BK4534","BK4588","LU1571399168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4585","BK4581","LU1983299246.USD","BBH","LU0208291251.USD","IE00B4R5TH58.HKD","BK4578","IE00BFTCPJ56.SGD","LU2242652126.USD","BIB","TBXU","BK4532","IBB","NVS","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","LU0289739699.SGD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","BK4007","IE0002141913.USD","AMGN","LU0211331839.USD","LU0889565916.HKD","IE0009355771.USD","PPH","LU0868494617.USD","LU0320765489.SGD","IBBQ","BK4566","LU0070302665.USD","LU1061106388.HKD","PBE","MEDX","BK4599","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258833","title":"安进股价盘前下跌5.4%；竞争对手诺华的胆固醇药物后期临床试验失败。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665258833?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:28","pubTimestamp":1788856084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BK4007","LU2089984988.USD","LU0868494617.USD","BIB","TBXU","BMED","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4588","LU1061106388.HKD","LU2112291526.USD","LU2242652126.USD","IE0002141913.USD","PSYK","MDTX","AMGN","BK4566","SG9999001440.SGD","LU0320765992.SGD","BK4578","LU1057294990.SGD","PPH","LU0289739699.SGD","BK4599","LU1023059063.AUD","BK4534","LU0122379950.USD","NVS","IBB","BK4532","LU0320765489.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","BK4581","LU0208291251.USD","LU0058720904.USD","LU0889565916.HKD","LU0109394709.USD","BBH","MEDX","IE00BJT1NW94.SGD","IBBJ","LU2468319806.SGD","LU0070302665.USD","BK4533","LU2242646821.SGD","PJP","BK4585","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富国银行上调安进目标价至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665349003?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B2B36J28.USD","IBB","LU1057294990.SGD","UUP","LU1571399168.USD","LU2112291526.USD","LU0122379950.USD","BK4581","LU0058720904.USD","PJP","IE00BJT1NW94.SGD","BK4585","LU0289739699.SGD","LU1983299246.USD","BIB","BK4599","IE0002141913.USD","BK4139","TBXU","SG9999001440.SGD","PGF","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2242652126.USD","LU0889565916.HKD","LU2242646821.SGD","BK4534","BK4588","LU0320765992.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","AMGN","IBBQ","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0868494617.USD","BBH","LU1023059063.AUD","UDN","BK4533","PBE","BK4582","BK4566","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周两度受挫！诺华(NVS.US)心脏病重磅药III期折戟，股价大跌安进(AMGN.US)“躺枪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665392789?lang=zh_cn&edition=full","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU0889565916.HKD","LU2242646821.SGD","PJP","LU0070302665.USD","BK4599","LU0868494617.USD","LU1061106388.HKD","LU0320765489.SGD","IE0009355771.USD","LU2242652126.USD","LU0109394709.USD","IBBQ","IE00BJJMRZ35.SGD","LU2089984988.USD","BK4588","BIB","BK4585","IBB","PBE","LU2112291526.USD","AMGN","IE0002141913.USD","BK4566","BK4139","IE00B2B36J28.USD","TBXU","LU0289739699.SGD","BK4007","LU1571399168.USD","MEDX","LU2468319806.SGD","PPH","BK4532","BK4533","LU0320765992.SGD","LU1057294990.SGD","BK4581","SG9999001440.SGD","LU1023059063.AUD","LU0211331839.USD","BK4578","IE00B4R5TH58.HKD","LU0122379950.USD","LU0208291251.USD","BK4534","IE00BJT1NW94.SGD","LU0058720904.USD","NVS","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194548","title":"安进（AMGN）罕见病药物Tavneos将于27年3月1日被彻底撤销英国上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194548","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664194548?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:59","pubTimestamp":1788350357,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英国药品监管机构MHRA宣布，暂停安进（AMGN）罕见病药物Avacopan Vifor（原商品名Tavneos）用于新患者，监管认定支撑该药物获批的关键临床试验数据已不可靠。该药2022年在英国获批，用于治疗两种罕见血管炎症自身免疫病。安进持有美国地区权益，由CSL集团（CSLLY）旗下CSLVifor负责英国等海外市场销售。新规9月1日落地，不再允许新患者启用该药物；为保障现有患者安全，设置6个月过渡用药期，2027年3月1日将彻底撤销其英国上市许可，现有患者可在此期间逐步更换替代治疗方案。安进方面公开表示不认可监管机构的决定，担忧该举措会对罕见病患者造成负面影响。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","SG9999001440.SGD","LU2242646821.SGD","LU1571399168.USD","LU0868494617.USD","PJP","LU0289739699.SGD","IE00BJT1NW94.SGD","BK4533","BK4139","LU0320765992.SGD","IE00BFTCPJ56.SGD","IBB","IE00B2B36J28.USD","LU1057294990.SGD","BK4581","AMGN","LU2089984988.USD","BK4585","BBH","AZNH","PBE","BK4588","LU0889565916.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242652126.USD","IPOS","TBXU","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","LU0122379950.USD","BK4534","BK4566","LU0058720904.USD","BIB","LU1023059063.AUD","IBBQ","LU1061106388.HKD","BK4599","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891714","title":"高盛9月“确信名单”更新：美股纳入福泰制药(VRTX.US) 欧股力推莱茵、Adyen和塔兰克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664891714?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0009355771.USD","LU0061475181.USD","SG9999001176.SGD","VGK","BK4588","LU0432979614.USD","LU0251131958.USD","LU2471134523.USD","BK4533","IE0002141913.USD","IE00B19Z9P08.USD","BK4585","LU1868836591.USD","BBH","BK4127","LU1674673691.USD","LU1791807156.HKD","VRTX","IE00BZ9MQY76.HKD","IDNA","SG9999001176.USD","LU1868836914.USD","LU2237443549.SGD","GNMX","LU1668664300.SGD","TBXU","LU2456880835.USD","LU0289739699.SGD","BK4550","LU1144417596.USD","LU2462157665.USD","BIB","LU2237438978.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","GSX","LU0096364046.USD","LU2471134952.CNY","LU0942090050.USD","IEV","IBBQ","IE00B19Z9Z06.USD","LU0868494708.USD","LU2468319806.SGD","LU1868837300.USD","LU2237443978.SGD","IBB","PBE","VXUS","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891705","title":"高盛9月“确信名单”更新：美股纳入福泰制药 欧股力推莱茵、Adyen和塔兰克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664891705?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季，高盛对其美国及欧洲市场的“确信名单”进行了更新，为投资者指明当前最看好的股票方向。本次调整中，美国名单新增一只大型生物科技股，欧洲名单则迎来三家新面孔。美国名单：新增福泰制药，移除盈透证券在美国市场，高盛将 $福泰制药$纳入确信名单，同时移除了 $盈透证券$，调整后名单保留23只股票。高盛还表示，塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VGK","LU2417539215.USD","SG9999001176.USD","UNHG","UNHW","COP","LU0345770993.USD","LU2362541273.HKD","VXUS","SG9999001176.SGD","MSFO","WFC","TBXU","LU1868836757.USD","MSFY","IE0002270589.USD","LU1585245621.USD","IBKR","GNMX","LU1069344957.HKD","MSFD","LU2456880835.USD","IE00BFTCPJ56.SGD","IEV","LU1868837136.USD","IE0004091025.USD","IE00B2B36J28.USD","IE0034235188.USD","LU2265009873.SGD","MSFT","PBE","XYZ","BK4504","DAL","MSFL","LU0889565916.HKD","XYZG","LU2750360641.GBP","LU0432979614.USD","MSFX","IE00BJT1NW94.SGD","IBB","LU0109394709.USD","LU2236285917.USD","BK4533","BK4532","IE00BFXG1179.USD","LU2468319806.SGD","IDNA","LU2471134879.HKD","MSFC","UNHU","LU2237443549.SGD","IBBQ","VRTX","MSFU","LU0106831901.USD","BK4585","LU2471134796.USD","GSX","BK4567","XYZY","EL","BIB","LU1868837300.USD","UNH","IE00B19Z3581.USD","LU2471134523.USD","UN","CRNX","BBH","MSFW","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.proshares.com/funds/bib.html","stockEarnings":[{"period":"1week","weight":-0.0738},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.3711},{"period":"6month","weight":0.4345},{"period":"1year","weight":0.9237},{"period":"ytd","weight":0.414}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.04688},{"month":2,"riseRate":0.5,"avgChangeRate":0.00449},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.010634},{"month":4,"riseRate":0.5625,"avgChangeRate":0.01003},{"month":5,"riseRate":0.529412,"avgChangeRate":0.011921},{"month":6,"riseRate":0.705882,"avgChangeRate":0.044992},{"month":7,"riseRate":0.647059,"avgChangeRate":0.05944},{"month":8,"riseRate":0.529412,"avgChangeRate":0.010833},{"month":9,"riseRate":0.352941,"avgChangeRate":-0.008265},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.005173},{"month":11,"riseRate":0.8125,"avgChangeRate":0.085975},{"month":12,"riseRate":0.5,"avgChangeRate":-0.001322}],"exchange":"NASDAQ","name":"Ultra纳斯达克生物科","nameEN":"ProShares Ultra Nasdaq Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ultra纳斯达克生物科(BIB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ultra纳斯达克生物科(BIB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ultra纳斯达克生物科,BIB,Ultra纳斯达克生物科股票,Ultra纳斯达克生物科股票老虎,Ultra纳斯达克生物科股票老虎国际,Ultra纳斯达克生物科行情,Ultra纳斯达克生物科股票行情,Ultra纳斯达克生物科股价,Ultra纳斯达克生物科股市,Ultra纳斯达克生物科股票价格,Ultra纳斯达克生物科股票交易,Ultra纳斯达克生物科股票购买,Ultra纳斯达克生物科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ultra纳斯达克生物科(BIB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ultra纳斯达克生物科(BIB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}